Miyake, N; Miyamoto, S; Jarskog, LF «New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?». Clinical Schizophrenia & Related Psychoses, vol. 6, 3, 10-2012, pàg. 122–33. DOI: 10.3371/CSRP.6.3.4. PMID: 23006237.
«Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis». Lancet, vol. 373, 9657, 1-2009, pàg. 31–41. DOI: 10.1016/S0140-6736(08)61764-X. PMID: 19058842.
«Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis». Lancet, vol. 382, 9896, 9-2013, pàg. 951–62. DOI: 10.1016/S0140-6736(13)60733-3. PMID: 23810019.
«A roadmap to key pharmacologic principles in using antipsychotics». Primary Care Companion to the Journal of Clinical Psychiatry, vol. 9, 6, 2007, pàg. 444–54. DOI: 10.4088/PCC.v09n0607. PMC: 2139919. PMID: 18185824.
Miyake, N; Miyamoto, S; Jarskog, LF «New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?». Clinical Schizophrenia & Related Psychoses, vol. 6, 3, 10-2012, pàg. 122–33. DOI: 10.3371/CSRP.6.3.4. PMID: 23006237.
«Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis». Lancet, vol. 373, 9657, 1-2009, pàg. 31–41. DOI: 10.1016/S0140-6736(08)61764-X. PMID: 19058842.
«Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis». Lancet, vol. 382, 9896, 9-2013, pàg. 951–62. DOI: 10.1016/S0140-6736(13)60733-3. PMID: 23810019.
«A roadmap to key pharmacologic principles in using antipsychotics». Primary Care Companion to the Journal of Clinical Psychiatry, vol. 9, 6, 2007, pàg. 444–54. DOI: 10.4088/PCC.v09n0607. PMC: 2139919. PMID: 18185824.
Sadock, Benjamin J.. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Sadock, Virginia A.,, Ruiz, Pedro. 11th, 2014, p. 318. ISBN 978-1-60913-971-1. OCLC881019573.